Neurophysiology

, Volume 48, Issue 4, pp 246–251 | Cite as

Effect of Cyclosporin A on the Viability of Hippocampal Cells Cultured under Conditions of Modeling of Alzheimer’s Disease

  • E. V. Kravenska
  • V. V. Ganzha
  • E. N. Yavorskaya
  • E. A. Lukyanetz
Article
First Online:
Received:

The presence of amyloid plaques and neurofibrillary tangles accompanied by manifestations of intense neurodegeneration in the brain is the main syndrome of Alzheimer’s disease (AD). Until now, the mechanisms underlying neurotoxic properties of the protein specific with respect to AD (amyloid β1–42) have not been fully interpreted. There are reasons to believe that the opening of mitochondrial permeability transition pores (MPTPs) may play a significant role in the respective processes. We estimated the impact of the mentioned protein on the viability of cultured hippocampal cells of rats. The use of confocal microscopy after staining of the cells by two dyes, Hoechst 33258 and propidium iodide, allowed us to measure the numbers of viable and necrotized units. When 2.0 μm of amyloid β1–42 was added to the culturing medium, the cell death index (CDI) of hippocampal cells (number of cells stained by propidium iodide normalized with respect to the number of examined units) on day in vitro (DIV) 14 was 59 ± 4%, on average, as compared with 28 ± 6% under control conditions. When not only amyloid β1–42 was added to the medium but cells were also treated with 1.25 μM of a MPTP blocker, cyclosporin A (CsA), the mean CDI was significantly smaller than that with no treatment (42 ± 6%; P < 0.05). Thus, changes in the mitochondria resulting in opening of MPTPs can be considerably involved in the process of necrotic death of hippocampal cells under conditions of modeling of AD.

Keywords

hippocampus cell culture amyloid β1–42 cyclosporin A viability necrosis mitochondrial permeability transition pore (MPTP) 
This is a preview of subscription content, log in to check access.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    V. T. Marchesi, “Alzheimer’s dementia begins as a disease of small blood vessels, damaged by oxidativeinduced inflammation and dysregulated amyloid metabolism: implications for early detection and therapy,” FASEB J., 25, 5-13 (2011).CrossRefPubMedGoogle Scholar
  2. 2.
    Y. Mu and F. H. Gage, “Adult hippocampal neurogenesis and its role in Alzheimer’s disease,” Mol. Neurodegener., 6, 85 (2011).CrossRefPubMedPubMedCentralGoogle Scholar
  3. 3.
    E. V. Kravenska, V. V. Chopovska, E. N. Yavorskaya, et al., “The role of mitochondria in the development of Alzheimer’s disease,” Tavrichesky Med.-Biol. Bull., 15, 147-149 (2012).Google Scholar
  4. 4.
    K. Ubhi and E. Masliah, “Alzheimer’s disease: recent advances and future perspectives,” J. Alzheimer’s Dis., 33, Suppl. 1, S185-S194 (2013).Google Scholar
  5. 5.
    J. Hardy, “A hundred years of Alzheimer’s disease research,” Neuron, 52, 3-13 (2006).CrossRefPubMedGoogle Scholar
  6. 6.
    E. A. Schon and E. Area-Gomez, “Mitochondria-associated ER membranes in Alzheimer disease,” Mol. Cell Neurosci., 55, 26-36 (2013).CrossRefPubMedGoogle Scholar
  7. 7.
    S. Kar, S. P. Slowikowski, D. Westaway, et al., “Interactions between beta-amyloid and central cholinergic neurons: implications for Alzheimer’s disease,” J. Psychiat. Neurosci., 29, 427-441 (2004).Google Scholar
  8. 8.
    J. Kang, H. G. Lemaire, A. Unterbeck, et al., “The precursor of Alzheimer’s disease amyloid A4 protein resembles a cell-surface receptor,” Nature, 325, 733-736 (1987).CrossRefPubMedGoogle Scholar
  9. 9.
    C. G. Glabe and R. Kayed, “Common structure and toxic function of amyloid oligomers implies a common mechanism of pathogenesis,” Neurology, 66, S74-S78 (2006).CrossRefPubMedGoogle Scholar
  10. 10.
    J. A. Hardy and G. A. Higgins, “Alzheimer’s disease: the amyloid cascade hypothesis,” Science, 256, 184-185 (1992).CrossRefPubMedGoogle Scholar
  11. 11.
    J. Hardy and D. J. Selkoe, “The amyloid hypothesis of Alzheimer’s disease: progress and problems on the road to therapeutics,” Science, 297, 353-356 (2002).CrossRefPubMedGoogle Scholar
  12. 12.
    G. Kroemer, L. Galluzzi, and C. Brenner, “Mitochondrial membrane permeabilization in cell death,” Physiol. Rev., 87, 99-163 (2007).CrossRefPubMedGoogle Scholar
  13. 13.
    A. Rasola and P. Bernardi, “The mitochondrial permeability transition pore and its involvement in cell death and in disease pathogenesis,” Apoptosis, 12, 815-833 (2007).CrossRefPubMedGoogle Scholar
  14. 14.
    E. V. Kravens’ka, N. V. Nalyvaiko, N. V. Fedirko, et al., “Kinetic analysis of the calcium- and cadmiuminduced development of nonspecific permeability of the mitochondrial inner membrane,” Neurophysiology, 40, 252-260 (2008).CrossRefGoogle Scholar
  15. 15.
    Y. Kravenskaya and N. V. Fedirko, “Mechanisms underlying interaction of zinc, lead, and cobalt with nonspecific permeability pores in the mitochondrial membranes,” Neurophysiology, 43, 163-172 (2011).CrossRefGoogle Scholar
  16. 16.
    T. E. Gunter, D. I. Yule, K. K. Gunter, et al., “Calcium and mitochondria,” FEBS Lett., 567, 96-102 (2004).CrossRefPubMedGoogle Scholar
  17. 17.
    E. Murphy, “Solving mitochondrial mysteries,” J. Mol. Cell Cardiol., 78, 1-2 (2014).CrossRefPubMedGoogle Scholar
  18. 18.
    P. Picone, D. Nuzzo, L. Caruana, et al., “Mitochondrial dysfunction: different routes to Alzheimer’s disease therapy,” Oxid. Med. Cell Longev., 2014, 1-11 (2014).CrossRefGoogle Scholar
  19. 19.
    V. M. Shkryl, L. M. Nikolaenko, P. G. Kostyuk, et al., “High-threshold calcium channel activity in rat hippocampal neurones during hypoxia,” Brain Res., 833, 319-328 (1999).CrossRefPubMedGoogle Scholar
  20. 20.
    V. M. Shkryl, P. G. Kostyuk, and E. A. Lukyanetz, “Dual action of cytosolic calcium on calcium channel activity during hypoxia in hippocampal neurones,” NeuroReport, 12, 4035-4039 (2001).CrossRefPubMedGoogle Scholar
  21. 21.
    E. A. Lukyanetz, V. M. Shkryl, O. V. Kravchuk, et al., “Action of hypoxia on different types of calcium channels in hippocampal neurons,” Biochim. Biophys. Acta – Biomembranes, 1618, 33-38 (2003).CrossRefGoogle Scholar
  22. 22.
    E. A. Lukyanetz, V. M. Shkryl, O. V. Kravchuk, et al., “Effect of hypoxia on calcium channels depends on extracellular calcium in CA1 hippocampal neurons,” Brain Res., 980, 128-134 (2003).CrossRefPubMedGoogle Scholar
  23. 23.
    Y. Zhou and W. L. Klein, “Ab oligomers-induced toxicity is attenuated in cells cultured with NbActiv4 medium,” Neurotox. Res., 22, 335-344 (2012).CrossRefPubMedPubMedCentralGoogle Scholar
  24. 24.
    K. M. Broekemeier, M. E. Dempsey, and D. R. Pfeiffer, “Cyclosporin A is a potent inhibitor of the inner membrane permeability transition in liver mitochondria,” J. Biol. Chem., 264, 7826-7830 (1989).PubMedGoogle Scholar
  25. 25.
    I. Szabo and M. Zoratti, “The giant channel of the inner mitochondrial membrane is inhibited by cyclosporin A,” J. Biol. Chem., 266, 3376-3379 (1991).PubMedGoogle Scholar
  26. 26.
    R. Abeti, A. Y. Abramov, and M. R. Duchen, “Betaamyloid activates PARP causing astrocytic metabolic failure and neuronal death,” Brain, 134, 1658-1672 (2011).CrossRefPubMedGoogle Scholar
  27. 27.
    S. J. Bertrand, M. V. Aksenova, M. Y. Aksenov, et al., “Endogenous amyloidogenesis in long-term rat hippocampal cell cultures,” BMC Neurosci., 12, 38 (2011).CrossRefPubMedPubMedCentralGoogle Scholar
  28. 28.
    Q. Liu, X. Xie, R. J. Lukas, et al., “A novel nicotinic mechanism underlies beta-amyloid-induced neuronal hyperexcitation,” J. Neurosci., 33, 7253-7263 (2013).CrossRefPubMedPubMedCentralGoogle Scholar
  29. 29.
    B. Connor, E. J. Beilharz, C. Williams, et al., “Insulinlike growth factor-I (IGF-I) immunoreactivity in the Alzheimer’s disease temporal cortex and hippocampus,” Brain Res. – Mol. Brain Res., 49, 283-290 (1997).CrossRefPubMedGoogle Scholar
  30. 30.
    J. K. Parks, T. S. Smith, P. A. Trimmer, et al., “Neurotoxic Ab peptides increase oxidative stress in vivo through NMDA-receptor and nitric-oxide-synthase mechanisms, and inhibit complex IV activity and induce a mitochondrial permeability transition in vitro,” J. Neurochem., 76, 1050-1056 (2001).CrossRefPubMedGoogle Scholar
  31. 31.
    H. L. Vieira, A. S. Belzacq, D. Haouzi, et al., “The adenine nucleotide translocator: a target of nitric oxide, peroxynitrite, and 4-hydroxynonenal,” Oncogene, 20, 4305-4316 (2001).CrossRefPubMedGoogle Scholar
  32. 32.
    S. A. Oakes, S. S. Lin, and M. C. Bassik, “The control of endoplasmic reticulum-initiated apoptosis by the BCL-2 family of proteins,” Curr. Mol. Med., 6, 99-109 (2006).CrossRefPubMedGoogle Scholar
  33. 33.
    R. Rizzuto, M. R. Duchen, and T. Pozzan, “Flirting in little space: the ER/mitochondria Ca2+ liaison,” Sci. STKE, 2004, re1 (2004).Google Scholar

Copyright information

© Springer Science+Business Media New York 2016

Authors and Affiliations

  • E. V. Kravenska
    • 1
  • V. V. Ganzha
    • 1
    • 2
  • E. N. Yavorskaya
    • 1
    • 2
  • E. A. Lukyanetz
    • 1
    • 2
  1. 1.Bogomolets Institute of Physiology. NAS of UkraineKyivUkraine
  2. 2.International Center for Molecular Physiology, NAS of UkraineKyivUkraine

Personalised recommendations